Error: Could not add to watchlist. X

Trillium Therapeutics Inc

+ Watchlist
SSS:CN
Ticker Change
SSS:CN has changed to a new ticker symbol
CAD
Volume
0
Previous Close
0.29
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (CAD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Trillium Therapeutics Inc. is an immuno-oncology company developing therapies for the treatment of cancer. The Company has preclinical programs, targeting the immunoregulatory pathways that tumor cells exploit to evade the host immune system. Trillium's programs include an antibody-like fusion protein that blocks molecules upregulated on malignancies, and a human monoclonal antibody.
ADDRESS
96 Skyway Avenue
Toronto, ON M9W 4Y9
Canada
PHONE
416-595-0627
  • Niclas Stiernholm
    President/CEO
  • James T Parsons
    Chief Financial Officer
  • Robert Uger "Bob"
    Chief Scientific Officer
  • Albert Agro
    Chief Medical Officer
  • Penka Petrova
    VP:Drug Development
Show More